This document is a consensus development conference guideline focused on the assessment and management of cognitive impairment associated with schizophrenia (CIAS) in Portugal. The scope involves input from Portuguese healthcare professionals, including six psychiatrists, a neuropsychologist, a psychiatric nurse, and two representatives from patient associations. The population for this consensus process included these specific experts and patient association representatives, though the sample size was not reported. The setting is Portugal.
The conference identified several challenges hindering routine assessment and treatment. These include a lack of validated assessment tools, absence of national guidelines, insufficient trained healthcare professionals, and limited access to cognitive remediation therapy (CRT). These limitations represent significant barriers to current practice in this region.
Opportunities to improve care were also highlighted. The authors suggest establishing national guidelines, using validated and practical assessment tools, training healthcare professionals, integrating CRT into standard care pathways, engaging caregivers, and strengthening collaboration between healthcare institutions. These steps aim to address the current gaps in care delivery.
Critical unresolved issues include the need for additional validated Portuguese assessment instruments and the establishment of cost-effectiveness data for CRT implementation. The practice relevance is improving the management of cognitive impairment in schizophrenia within the Portuguese healthcare system. The authors caution that further work is needed to resolve these specific gaps before widespread implementation can be fully supported.
View Original Abstract ↓
Cognitive impairment is a key contributor to the functional disability seen in schizophrenia, yet it remains one of the most underdiagnosed and poorly managed aspects of the disorder. In Portugal, schizophrenia imposes a significant socio-economic burden, with notable gaps in the assessment and treatment of cognitive impairment.
A panel of Portuguese healthcare professionals, including six psychiatrists with clinical and academic expertise, a neuropsychologist, a psychiatric nurse, and two representatives from patient associations, reviewed current evidence and practices for managing cognitive impairment in schizophrenia. The panel addressed three primary clinical questions using a consensus development conference methodology (1): What is the current state of CIAS (cognitive impairment associated with schizophrenia) assessment and management in Portugal? (2) What are the major barriers to optimal care? (3) What recommendations can improve CIAS care within the Portuguese healthcare system?
Several challenges hinder the routine assessment and treatment of cognitive impairment in Portugal, including the lack of validated assessment tools, the absence of national guidelines, insufficient trained healthcare professionals, and limited access to cognitive remediation therapy (CRT). Key opportunities that could improve care include establishing national guidelines for cognitive assessment and management, using validated and practical assessment tools, training healthcare professionals, integrating CRT into standard care pathways, engaging caregivers, and strengthening collaboration between healthcare institutions.
Despite significant challenges, the Portuguese healthcare system has numerous opportunities to improve the management of cognitive impairment in schizophrenia. Critical unresolved issues include the need for additional validated Portuguese assessment instruments and the establishment of cost-effectiveness data for CRT implementation in the Portuguese context.